Effects of Pectin on Flora Intestinal Colonization and Maintenance After Fecal Transplantation
NCT02016469 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2013-12-20
Summary
The purpose of this study is to evaluate the effect and safety of pectin and fecal microbiota transplantation on patients with inflammatory bowel disease. The investigators hypothesize that patients who take pectin can promote the migration of probiotics in intestine engraftment, reduce pathogenic agents'adhesion to intestinal mucosa, cut down the inflammation, and to maintain intestinal flora diversity and steady state in a long time.
Conditions
Interventions
- OTHER
-
co-transplantation of FMT and pectin
300ml Bacterial suspension (from 60g fresh stool )for fecal microbiota transplantation the first day and 20g pectin given continuously for total five days
- OTHER
-
single fecal microbiota transplantation
single fecal microbiota transplantation once the first day
- DIETARY_SUPPLEMENT
-
pure give pectin 20g/d for five days
pure give pectin 20g/d for five days
Sponsors & Collaborators
-
Jinling Hospital, China
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-12-31
- Primary Completion
- 2015-12-31
- Completion
- 2016-02-29
Countries
- China
Study Locations
More Related Trials
-
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in IBS
NCT04214470 ·Status: WITHDRAWN
-
Regulation of Vitamin D Metabolism by Washed Microbiota Transplantation in Patients With IBD
NCT04989374 ·Status: UNKNOWN
-
Research on the Use of Probiotics in the Prevention and Treatment of Inflammatory Bowel Disease
NCT06781827 ·Status: RECRUITING ·Phase: NA
-
Dynamic Changes of Gut Microbiota in UC After FMT
NCT03949257 ·Status: UNKNOWN ·Phase: NA
-
Pectin, Aging and Intestinal Barrier Function
NCT02376270 ·Status: COMPLETED ·Phase: PHASE4
-
FMT for Patients With IBS With Fecal and Mucosal Microbiota Assessment
NCT03125564 ·Status: COMPLETED ·Phase: NA
-
Clinical Study of Selective Fecal Microbiota Transplantation in the Treatment of Irritable Bowel Syndrome.
NCT04890405 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of FMT for the Treatment of IBS-D and Mental Health Comorbidity in Young Adults
NCT06297421 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Neural Circuit Mechanism of Inflammatory Bowel Disease Combined With Depression
NCT06471894 ·Status: NOT_YET_RECRUITING
-
Multi-Strain Probiotics Supplementation With Standard Care in Mild to Moderate Ulcerative Colitis
NCT06595719 ·Status: RECRUITING ·Phase: NA
-
Microbiota and Immune microEnvironment in Pouchitis
NCT03136419 ·Status: UNKNOWN ·Phase: NA
-
Pathophysiological Effects of Persistently Colonized Microbiome on Irritable Bowel Syndrome
NCT06013410 ·Status: RECRUITING ·Phase: NA
-
Gut Microbiota Reconstruction in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea
NCT02651740 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Effect Dietary Fibre Supplementation on Gut Microbiota Composition
NCT06758570 ·Status: COMPLETED ·Phase: NA
-
Probiotic Intervention for Gut Function
NCT05155449 ·Status: COMPLETED ·Phase: NA
-
Fecal Microbiota Transplantation for Irritable Bowel Syndrome
NCT03613545 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Efficacy of Fecal Microbiota Transplantation (FMT) in Irritable Bowel Syndrome (IBS)
NCT06201182 ·Status: RECRUITING ·Phase: NA
-
Efficacy of Low-FODMAPs Dietary Therapy for Irritable Bowel Syndrome in China
NCT03304041 ·Status: COMPLETED ·Phase: NA
-
Modified antioxIdants Bacteria for Gut Inflammation
NCT06189599 ·Status: ENROLLING_BY_INVITATION
-
Gut Microbiota Dysbiosis and Translocation During IBD and Parkinson
NCT04159727 ·Status: COMPLETED ·Phase: NA
-
FMT for Post-infectious IBS
NCT05461833 ·Status: COMPLETED ·Phase: NA
-
Changes in Microbiota and Quality of Life in IBS
NCT05266287 ·Status: UNKNOWN ·Phase: NA
-
Analysis of Microbiota Changes Induced by Microencapsulated Sodium Butyrate in Patients With Inflammatory Bowel Disease
NCT04879914 ·Status: COMPLETED ·Phase: NA
-
Modulation of Intestinal Barrier Function and Inflammation Via Butyrate-promoting Dietary Fibre
NCT05058131 ·Status: UNKNOWN ·Phase: NA
-
Effect of Semi-vegetarian Diet in Inflammatory Bowel Disease Patients With Clinical Remission
NCT04835727 ·Status: COMPLETED ·Phase: NA